Member Info for roger65

So is that the offending trade that caused the suspension and has only just been settled and hence why trading might resume tomorrow morning?

Wasn't that close to the amount raised in the retail offer? All very odd.

Can anyone explain these two trades reported from yesterday? A buy of £132k and then immediately cancelled. How has that happened? Very odd. Or have they been there all along and I've just missed them?

Having read all of the public consultation documents, from which I formed a fairly negative opinion of the NICE outcome - and I wasn't the only one - and despite evidence to the contrary from GDR itself in terms of it's terrible financial situation, I am actually a little more confident of a good outcome. Why? I simply read the forward looking statement from NHS chair that Lionel posted a link to. Read it.

I came to the conclusion from that that there is a feeling of inevitability from with the NHS bosses that pharmacogenomics is going to be a major part of the way medical services will operate in the longer term and that at some point they are simply going to have to make a start in bringing the science on board. If they wait until everything is known and all safely organised then it could be decades before things in the NHS improves. It's too big, under funded and oversubscribed too by UK citizens. All entitled to it of course but unless some serious leap of faith in taking this technology on board and making a start on creating a national register of every single individuals DNA then doctors will always be working reactively to a patient's needs rather than having the ability to be proactive and making some preventative decisions for the long term benefit to all patients and in the process saving both the NHS and the UK Govt from wasting ever more money on old and less efficient/accurate systems to treat patients. the NHS Chair is adamant this is the way forward. There are hints in the NICE public consultation documents that the panel are taking all the negative comments thrown at it from those with a vested interest in GDR failing to get these tests adopted nationally and have come back with a level toned response that still points to them being supportive of CYP2C19 being used when ever possible and feasible. Once these tests are in place nationally I hope it will lead to obvious evidence that they work and save the NHS money and from that other countries will start to adopt the GDR kits.

In the mean time the sp is taking one of it's usual mid- week dips...

'No way this is going below 1p'

We're at 1.04p. That's a very brave call Lloyd.

I will be delighted if the sp rises but I've just seen far too many scams on AIM to ever trust these BODs. This one is one of the really bad lot imho and if this does come back to market AND the sp rises then I will count myself very lucky indeed.

Doesn't matter what the mcap was in the past. There has been a reset. The mcap is £3m with nearly 3 billion shares in issue. That's it. There is no rerate now unless the BOD delivers concrete news that hasn't been tampered with by the Nomad or any ii behind the recent placing.

It's AIM and it stinks but put that together with a truly awful and negligent CEO and you've a recipe for a proper disaster for share holders. If I'm wrong then I'm wrong. Wouldn't be the first time by any means but...I'm not confident.

First thing is first let's see confirmation CPX will resume trading. Can they release an RNS at 7am tomorrow stating it will resume just one hour later when the markets open? Or does it have to be longer notice than that?

Lloyd - do you mean who is selling all these shares?? Twice as many sold as bought today. Going to be like that for quite a while before this is ready to start a slow climb back to where we were before the BODs did the dirty. Fell sorry for anyone who bought on that RNS only to be so quickly duped. Shabby treatment of existing share holders and worse, will frighten off any new investors after such a stunt. For any future rise they will have to deliver some concrete news, and that will be pored over far more carefully by any retail investors after this recent rug-pull. How long until some decent news I wonder. If results in July aren't good, then what?

I agree AIM, it must have been approved by the Nomad but considering who the Nomad is I then think they probably are in on what ever the scheme is here.

As for 400% once/if this comes back to market I highly doubt that. If I had put £2m of my money into a company on the brink of administration I would want to get my money back asap. If this starts to rerate then the placee will be dumping shares galore - 1.9 BILLION of them - well before the sp gets anywhere near .5p!

If trading does resume tomorrow and is confirmed by LSE in an RNS then I can easily imagine after that massive dilution the sp will either drop or hover where it is. Some say it's curretnly priced for administration but not so if this £2m placing goes through. It resets the bar at .1p. The company will have to come up with something concrete in an RNS to prove it's worth investing in from here on in, especially considering the lack of humility from the CEO, by which I mean not a word of apology for taking the company into two legal disputes (that both failed to win) and a decline in share price of over 95% in less than six months. How can anyone trust this person going forward? Clearly his decision making is appalling and even before the company is back on its feet it has been suspended for several weeks, he's busy appointing more and more Directors who will all have to be paid out of the recent placing funds. It doesn't inspire confidence really.

I don't expect anyone here to stick around if the sp goes as high as .2p. Many will sell and count their blessings to get out with at least something. Lars is a car crash of a Director and will only lead this company into more trouble. Just a matter of time. And don't forget, we have no idea what he has promised who ever it is that has provided £1.9m for the funding. If they hold the vast majority of shares there will be nothing to stop them from buying the company for peanuts as they will hold most of the votes in any share holder approval required for such a situation. Still think we've been sold out and will end up with nothing and Lars will keep his job and salary and act as if nothing untoward has happened.

? Don't think we can resume trading without an RNS prior to the whistle being blown... or am I wrong on that?

Must still be something weird going on or LSE would just clear the matter up and allow things to return to normal.

The appointment of several new Directors does of course mean the £2m raised is going to be spent pretty quickly on salaries whilst the company still has little or no income. All highly irregular.

Hmmm still no confirmation from LSE that reading will resume tomorrow. Have CPX directors jumped the gun perhaps? Will be watching for the little red dot today.

Game of two halves today. Loads of buying this morning but mostly sells since just after lunch.

What does tomorrow hold I wonder...a TR1 would be cool

At least Bob Holt's purchase of shares is now listed above. £350k of his own wonga is a decent start. Intrigued as to where this might lead. Just can't be as bad as the sham from whence it came.....Verditek. Gives me the shivers just thinking about it.

This dude bob Holt as an incredible track record. Really amazing.

The placing price is at 0.1p. Why would it drop a further 90%?

Don't see it jumping 400% though either. If it does then what would you do if you held those 2 BILLION new shares? Quick and easy profit me thinks. Double your money and sell them at .2p. All depends if they're in sticky hands or not.

First thing is first though it would be good to get LSE confirmation about Trading resuming on Thursday. Don't think Lars or the Nomad would have been silly enough to put that date in an RNS unless they already knew that was when it will re-open.

Stockpick - I think cheek is banking on draft Full recommendation being given at the end of this week. IF it lands and they even give out a rough estimate of how many tests might be used by the NHS in the near future (per year) then the sp will fly and a placing hopefully done on the back of such a rise. That's my only hope realistically not to be shafted twice by this stock and my own poor decisions.

And what about a damp squib? lol

Agh 5085 that's mean. I lost out big time on EUA and it still hurts but thanks for the reminder. I wasn't the only one to lose there and EUA is typical of the AIM lies that are foisted on retail investors. What a huge con that turned out to be. Share price went from 4op+ to 1.5p. Ouch

The report suggests the test could be used for approx 35k cases but, as pointed out by Jimi, there isn't the capacity in the lab testing set up to cope with the increased demand. There is also a time factor so I'm thinking the CYP2C19 test may be used in the region of 35k - 50k times. That would still amount to about £3.5 - £4m worth of revenue (not profit). Anything like those figures will change the landscape here. Still worried about the pervasive negative comments from outside sources though within the report. Bit of a knife edge here now - hasn't that been said before of GDR?!

Looks like PEEL want to keep the sp at this level for the time being. Never a level playing field between retail and the pro's

I did Parkez. It says 'It is EXPECTED that Admission will become effective, and dealings in the New Ordinary Shares will commence, at 8:00 a.m. BST on 25 April 2024'

So in fact this isn't confirmed...yet. So now we are expecting another RNS very soon with this confirmed by the LSE.

Where is this news on resuming trading on Thursday? Tks

LSE seems to only have one RNS for CPX today. Hopeless as usual.

Yep hands up AHS. Wrong again. Still not happy with the way the way the BODs have handled everything this last year though. Pleasant surprise to be coming back to market but still no idea how the sp will react to such a massive dilution.

The public Consultation ends on Friday I think and it's possible a draft recommendation will be made but not officially published until July.

If it becomes clear it's not a FULL recommendation - and I take Muminr's points on board that NICE seem to be indicating it will be FULL - then it will be a bad weekend for share holders here. That might in fact precipitate GDR going private or being sold on the cheap. I think for now though Cheek doesn't want to go down that route. He appears to want to be rid of RF and get funding through other means and get the FDA partner announced asap. Someone's already said it, chicken and egg. IMO it's all hanging on this next bit of news from NICE. Hopefully it's good. If it is then sp should fly.